-
1
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
Diabetes Control and Complications Trial Research Group
-
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
-
(1993)
N Engl J Med
, vol.329
, pp. 977-986
-
-
-
2
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group
-
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
3
-
-
3042841305
-
Tests of glycemia in diabetes
-
Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-73.
-
(2004)
Diabetes Care
, vol.27
, pp. 1761-1773
-
-
Goldstein, D.E.1
Little, R.R.2
Lorenz, R.A.3
Malone, J.I.4
Nathan, D.5
Peterson, C.M.6
Sacks, D.B.7
-
4
-
-
48149095259
-
Translating the A1C assay into estimated average glucose values
-
for the A1c-Derived Average Glucose (ADAG) Study Group
-
Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, for the A1c-Derived Average Glucose (ADAG) Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-8.
-
(2008)
Diabetes Care
, vol.31
, pp. 1473-1478
-
-
Nathan, D.M.1
Kuenen, J.2
Borg, R.3
Zheng, H.4
Schoenfeld, D.5
Heine, R.J.6
-
5
-
-
0029785455
-
The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial
-
Diabetes Control and Complications Trial Research Group
-
Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-98.
-
(1996)
Diabetes
, vol.45
, pp. 1289-1298
-
-
-
6
-
-
29144453326
-
Intensive treatment and cardiovascular disease in patients with type 1 diabetes
-
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group
-
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53.
-
(2005)
N Engl J Med
, vol.353
, pp. 2643-2653
-
-
-
7
-
-
75149180515
-
Standards of medical care in diabetes - 2010
-
American Diabetes Association
-
American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl 1):S11-61.
-
(2010)
Diabetes Care
, vol.33
, Issue.SUPPL. 1
-
-
-
8
-
-
0036089730
-
Biological variation of glycohemoglobin
-
Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, et al. Biological variation of glycohemoglobin. Clin Chem 2002;48:1116-8.
-
(2002)
Clin Chem
, vol.48
, pp. 1116-1118
-
-
Rohlfing, C.1
Wiedmeyer, H.M.2
Little, R.3
Grotz, V.L.4
Tennill, A.5
England, J.6
-
9
-
-
54049105337
-
Frequency of HbA1c discordance in estimating blood glucose control
-
Cohen RM, Smith EP. Frequency of HbA1c discordance in estimating blood glucose control. Curr Opin Clin Nutr Metab Care 2008;11:512-7.
-
(2008)
Curr Opin Clin Nutr Metab Care
, vol.11
, pp. 512-517
-
-
Cohen, R.M.1
Smith, E.P.2
-
10
-
-
0036673526
-
Distribution of HbA1c levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey
-
Saaddine JB, Fagot-Campagna A, Rolka D, Narayan KMV, Geiss L, Eberhardt M, Flegal KM. Distribution of HbA1c levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey. Diabetes Care 2002;25:1326-30.
-
(2002)
Diabetes Care
, vol.25
, pp. 1326-1330
-
-
Saaddine, J.B.1
Fagot-Campagna, A.2
Rolka, D.3
Narayan, K.M.V.4
Geiss, L.5
Eberhardt, M.6
Flegal, K.M.7
-
11
-
-
56149118421
-
Effect of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004
-
Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, et al. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care 2008;31:1991-6.
-
(2008)
Diabetes Care
, vol.31
, pp. 1991-1996
-
-
Pani, L.N.1
Korenda, L.2
Meigs, J.B.3
Driver, C.4
Chamany, S.5
Fox, C.S.6
-
12
-
-
2542426036
-
Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes
-
McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004;27:1259-64.
-
(2004)
Diabetes Care
, vol.27
, pp. 1259-1264
-
-
McCarter, R.J.1
Hempe, J.M.2
Gomez, R.3
Chalew, S.A.4
-
13
-
-
34347406488
-
The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial
-
Lachin JM, Genuth S, Nathan DM, Rutledge BN. The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the Diabetes Control and Complications Trial. Diabetes. 2007;56:1913-21.
-
(2007)
Diabetes
, vol.56
, pp. 1913-1921
-
-
Lachin, J.M.1
Genuth, S.2
Nathan, D.M.3
Rutledge, B.N.4
-
15
-
-
0042170249
-
Discordance between HbA1c and fructosamine: Evidence for a glycosylation gap and its relation to diabetic nephropathy
-
Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 2003;26:163-7.
-
(2003)
Diabetes Care
, vol.26
, pp. 163-167
-
-
Cohen, R.M.1
Holmes, Y.R.2
Chenier, T.C.3
Joiner, C.H.4
-
16
-
-
0025939699
-
Clinical validation of a second-generation fructosamine assay
-
Cefalu WT, Bell-Farrow AD, Petty M, Izlar C, Smith JA. Clinical validation of a second-generation fructosamine assay. Clin Chem 1991;37:1252-6.
-
(1991)
Clin Chem
, vol.37
, pp. 1252-1256
-
-
Cefalu, W.T.1
Bell-Farrow, A.D.2
Petty, M.3
Izlar, C.4
Smith, J.A.5
-
17
-
-
33646451956
-
Carbohydrates
-
Burtis CA, Ashwood ER, Bruns DE, eds. 4th ed. St. Louis: Elsevier Saunders
-
Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. St. Louis: Elsevier Saunders; 2006. p 837-902.
-
(2006)
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics
, pp. 837-902
-
-
Sacks, D.B.1
-
18
-
-
0033302577
-
Determination of reference values for a novel ketoamine-specific fructosamine assay for assessment of diabetic glycemic control
-
O'Brien JE, Brookes M. Determination of reference values for a novel ketoamine-specific fructosamine assay for assessment of diabetic glycemic control. Diabetes Technol Ther 1999;1:447-55.
-
(1999)
Diabetes Technol Ther
, vol.1
, pp. 447-455
-
-
O'Brien, J.E.1
Brookes, M.2
-
19
-
-
0035134867
-
Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin
-
Review
-
Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin [Review]. Clin Chem 2001;47:153-63.
-
(2001)
Clin Chem
, vol.47
, pp. 153-163
-
-
Bry, L.1
Chen, P.C.2
Sacks, D.B.3
|